Drug Discovery Informatics Market Report Research Report - Forecast Till 2030

Drug Discovery Informatics Market Share, Trends And Size Analysis By Product (Discovery Informatics, Development Informatics), Mode (In-House Informatics), Service (Clinical Trial Data Management, Molecular Modeling), & End User—Forecast Till 2030

ID: MRFR/HC/6360-HCR | November 2022 | Region: Global | 90 Pages         

Drug Discovery Informatics Market

Drug Discovery Informatics Market is expected to reach USD 6.3 billion at CAGR of 10.8% by 2022-2030.

Segmentation

By Product Discovery Informatics Development Informatics
By Mode In-House Informatics
By Service Clinical Trial Data Management Molecular Modeling

Key Players

  • Thermo Fisher Scientific
  • PerkinElmer
  • Certara
  • L.P.
  • Infosys Limited
  • Novo Informatics Pvt. Ltd.
  • Collaborative Drug Discovery Inc.
  • Selvita
  • Charles River Laboratories
  • International Business Machines Corporation
  • Jubilant Life Sciences Ltd.
  • IO Informatics

Drivers

  • Rising R&D expenditure
  • increasing support for research
  • increasing use of informatics in drug development
Speak to Analyst Request a Free Sample

Drug Discovery Informatics Market Overview
 
The drug discovery informatics market is expected to reach USD 6.3 billion by 2030 at CAGR of 10.8% during the forecast period 2022-2030. In the field development process, well-completion is a crucial phase. Any good development's economic feasibility is mainly contingent on how the well is completed. Well, completions outline the process of designating a well for commercial operation. The well begins to produce fluids normally after the completion well is correctly completed. A proper completion procedure's main goal is to mechanically connect the wellbore and the reservoir. Throughout the process, coiled tubing, packers, completion fluids, manifolds, wellheads, and blowout preventers are all employed. Shortly, another area of market expansion is projected to be supply chain re-alignment.
 
Factors such as increased exploration and drilling activities, oil price recovery, and higher demand for oilfield services are driving market expansion. The continuous development in the discovery of new oilfields is driving the market for well completion. Furthermore, service and equipment will be required for the completion of wells by putting wellheads on top of cased wells, as part of the field development initiatives that began a few years ago. For instance, Ghana's Jubilee oilfield, which is nearing completion, will begin production. The restored oil prices, as well as the continued bubbling from newly discovered petroleum sources, offer significant possibilities to well-completed service vendors. During the projection period, service providers are expected to continue to grow.

Segmentation


The drug discovery informatics market has been segmented into product, mode, service, end user, and region.


By product, the market has been segmented into discovery informatics and development informatics.


On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 


By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.


Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.


The drug discovery informatics market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The drug discovery informatics market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. 


The European drug discovery informatics market has been segmented into Western Europe and Eastern Europe. The Western Europe drug discovery informatics global market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The drug discovery informatics global market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The drug discovery informatics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


Few of the spearheads in the drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.


Regional Market Summary
Drug Discovery Informatics Market Share
Global Drug Discovery Informatics Market Share (%), by Region, 2017

Geographically, the Americas spearheaded the drug discovery informatics market in 2017. This is owing to the presence of major market value participants (Thermo Fisher Scientific, Inc., PerkinElmer, Inc., International Business Machines Corporation) and sophisticated healthcare infrastructure, flourishing pharmaceutical and biotechnology industries, and developments of next-generation sequencing and chemical laboratories in the US and Canada.


Europe would be the second largest contributor in terms of value during next five years attributed to the financial support provided by the government for research and development in drugs, growth in the therapeutic discovery ventures and activities carried out by research and academic institutes, universities, and other centers.


Asia-Pacific is expected to represent profitable market growth from 2018 to 2023 owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region. For instance, Asia-Pacific offers a substantial cost saving advantage, with savings ranging from 50% to 80% of the cost in comparison with the developed nations, thereby resulting into a rise in the volume of clinical trials being conducted in this region.


The drug discovery informatics market in the Middle East & Africa would witness the modest market growth rate from 2018 to 2023. The Middle East and North Africa (MENA) region constitutes 2% of global pharmaceutical sales. Rampant growth in population has fueled drug demand especially for higher-yield pharmaceutical products attracting the attention of multinational pharmaceutical companies in the MENA region.

Recent Development


National Oilwell Varco, Inc. (United States) did mergers and acquisitions which were the most prevalent method used by the market's top players, accounting for over a third of the total development share. New product releases, contracts and agreements, and expansions followed, in that order.
 
Maersk Drilling, a Danish offshore drilling contractor, said in November 2021 that it has reached a definitive agreement to merge with Noble Corporation, a US rival, in a largely all-stock transaction that will produce a merged business with a fleet of 20 floaters and 19 jack-up rigs.

Drug Discovery Informatics Market, by Product



  • Discovery Informatics

  • Development Informatics


Drug Discovery Informatics Market, by Mode



  • In-house Informatics

  • Outsourced Informatics


Global Drug Discovery Informatics Market, by Service



  • Sequencing and Target Data Analysis

  • Docking

  • Molecular Modeling

  • Clinical Trial Data Management

  • Others


Drug Discovery Informatics Market, by End User



  • Pharmaceutical and Biotechnology Industries

  • Contract Research Organizations (CROs)

  • Others


Drug Discovery Informatics Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe



  • Eastern Europe

    • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




Drug Discovery Informatics Market, by Key Players



  • Thermo Fisher Scientific, Inc.

  • PerkinElmer, Inc.

  • Certara, L.P.

  • Infosys Limited

  • Novo Informatics Pvt. Ltd.

  • Collaborative Drug Discovery Inc.

  • Selvita

  • Charles River Laboratories, Inc.

  • International Business Machines Corporation

  • Jubilant Life Sciences Ltd.

  • IO Informatics, Inc.

  • GVK Biosciences Private Limited

  • Dassault Systèmes


Intended Audience



  • Drug discovery informatics providers

  • Venture capitalists

  • Pharmaceutical companies

  • Biotechnology companies

  • Research and academic institutes

  • Government associations

  • Association and government bodies

  • Market research and consulting service providers

  • Corporate entities



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 6.3 billion
  CAGR   10.8% 2022-2030
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Mode, Service, End user,
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising worldwide focus on drug discovery
  • Growing need to control drug discovery and development costs
  • Growth in R&D expenditure
  • Increasing burden of chronic diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Drug discovery informatics market was valued at more than USD 6.3 billion in 2030.

    Leading players in the drug discovery informatics market include Thermo Fisher Scientific, Infosys, Certara, Selvita, and Jubilant Life Sciences, among others.

    The increasing investment in drug discovery applications is likely to be a major driver for the global drug discovery informatics market.

    The Americas spearhead the global drug discovery informatics market, followed by Europe.

    Drug discovery informatics market is expected to exhibit a solid 10.8% CAGR over the forecast period from 2022 to 2030